

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi pipeline outages, pressuring stocks ahead of the Fed.
You can purchase shares of Quest Diagnostics (NYSE:DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Guardant Health Inc (NASDAQ:GH) and Fresenius Medical Care AG (NYSE:FMS).
Quest Diagnostics has a consensus price target of $213.39.
The stock price for Quest Diagnostics (NYSE: DGX) is $241.89 last updated October 23, 2026 at 4:02 PM EDT.
There are no upcoming dividends for Quest Diagnostics.
Quest Diagnostics does not have any upcoming earnings scheduled.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing...